跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,676 条关于
“AP3”
全部
2,676
临床试验
2,008
药物
496
机构
52
资讯
120
去年
Acrivon Therapeutics to Showcase AP3 Platform and Clinical Program Updates at Upcoming R&D Event
去年
Acrivon Therapeutics Initiates Phase 1 Trial of WEE1/PKMYT1 Inhibitor ACR-2316 for Solid Tumors
去年
Acrivon Therapeutics Grants Equity Awards to Employees Under Nasdaq Rule 5635(c)(4)
2年前
Acrivon's ACR-368 Shows Promise in Endometrial Cancer, ACR-2316 Advances to Clinic
2年前
Acrivon Therapeutics' ACR-368 Shows Promise in Endometrial Cancer; ACR-2316 Cleared for Phase 1 Trials
7个月前
Acrivon Therapeutics Launches CLIA-Certified Laboratory to Advance Precision Medicine Development
去年
Acrivon Therapeutics Appoints Renowned Oncologist Dr. Mansoor Raza Mirza as Chief Medical Officer to Lead Clinical Development
2个月前
Alebund Pharmaceuticals Debuts on Hong Kong Stock Exchange, Raising $164 Million to Advance Broad Renal Pipeline
去年
FDA Grants Breakthrough Device Status to Acrivon's AI-Powered Cancer Diagnostic Platform
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
第 1 页,共 12 页
上一页
下一页